M.D. Manuel Litchman - 24 Apr 2023 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role
President and CEO, Director
Signature
/s/ Matthew Wein, Attorney-in-Fact
Issuer symbol
MBIO
Transactions as of
24 Apr 2023
Net transactions value
$0
Form type
4
Filing time
07 Jul 2023, 16:06:00 UTC
Previous filing
04 Jun 2024
Next filing
04 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBIO COMMON STOCK, PAR VALUE $0.0001 Award $0 +5,000 +4.7% $0.000000 111,079 24 Apr 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of 5,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2027.
F2 Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
F3 Includes restricted share units, which vest over various time periods.